The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts

Genetic Epidemiology

Volumn 33, Issue 3, 2009, Pages 237-246

  Karvanen, Juha ^a   Silander, Kaisa ^a,b   Kee, Frank ^c   Tiret, Laurence ^d   Salomaa, Veikko ^a   Kuulasmaa, Kari ^a   Wiklund, Per Gunnar ^e   Virtamo, Jarmo ^a   Saarela, Olli ^a   Perret, Claire ^d   Perola, Markus ^a,b   Peltonen, Leena ^d   Cambien, Francois ^d   Erdmann, Jeanette ^f   Samani, Nilesh J ^g   Schunkert, Heribert ^g   Evans, Alun ^c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UMEÅ UNIVERSITY   (Sweden)

^f UNIVERSITY OF LÜBECK   (Germany)

^g UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cardiovascular disease; Genes; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHROMOSOME 9P; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FINLAND; FRANCE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHENOTYPE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; UNITED KINGDOM;

CHROMOSOMES, HUMAN, PAIR 9; COHORT STUDIES; CORONARY DISEASE; FINLAND; FRANCE; HUMANS; MORTALITY; NORTHERN IRELAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; SWEDEN;

EID: 66249120705     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.20374     Document Type: Article

References (31)

1. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O'Donnell CJ. 2007. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 115:2878-2901.
2. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 57:289-300.
3. Cai J, Zeng D. 2004. Sample size/power calculation for case-cohort studies. Biometrics 60:1015-1024.
4. Cambien F, Tiret L. 2007. Genetics of cardiovascular diseases: from single mutations to the whole genome. Circulation 116:1714-1724.
5. Cavalli-Sforza LL, Piazza A. 1993. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet 1:3-18.
6. Clark AG, Boerwinkle E, Hixson J, Sing CF. 2005. Determinants of the success of whole-genome association testing. Genome Res 15:1463-1467.
7. Dupuis J, O'Donnell CJ. 2007. Interpreting results of large-scale genetic association studies: separating gold from fool's gold. J Am Med Assoc 297:529-531.
8. Evans A, Salomaa V, Kulathinal S, Asplund K, Cambien F, Ferrario M, Perola M, Peltonen L, Shields D, Tunstall-Pedoe H, Kuulasmaa K. 2005. MORGAM (an international pooling of cardiovascular cohorts). Int J Epidemiol 34:21-27.
9. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, Masson G, Gudbjartsson DF, Magnusson KP, Andersen K, Levey AI, Backman VM, Matthiasdottir S, Jonsdottir T, Palsson S, Einarsdottir H, Gunnarsdottir S, Gylfason A, Vaccarino V, Hooper WC, Reilly MP, Granger CB, Austin H, Rader DJ, Shah SH, Quyyumi AA, Gulcher JR, Thorgeirsson G, Thorsteinsdottir U, Kong A, Stefansson K. 2007. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316:1491-1493.
10. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, Manolescu A, Jones GT, Rinkel GJ, Blankensteijn JD, Ronkainen A, Jaaskelainen JE, Kyo Y, Lenk GM, Sakalihasan N, Kostulas K, Gottsater A, Flex A, Stefansson H, Hansen T, Andersen G, Weinsheimer S, Borch-Johnsen K, Jorgensen T, Shah SH, Quyyumi AA, Granger CB, Reilly MP, Austin H, Levey AI, Vaccarino V, Palsdottir E, Walters GB, Jonsdottir T, Snorradottir S, Magnusdottir D, Gudmundsson G, Ferrell RE, Sveinbjornsdottir S, Hernesniemi J, Niemela M, Limet R, Andersen K, Sigurdsson G, Benediktsson R, Verhoeven EL, Teijink JA, Grobbee DE, Rader DJ, Collier DA, Pedersen O, Pola R, Hillert J, Lindblad B, Valdimarsson EM, Magnadottir HB, Wijmenga C, Tromp G, Baas AF, Ruigrok YM, van Rij AM, Kuivaniemi H, Powell JT, Matthiasson SE, Gulcher JR, Thorgeirsson G, Kong A, Thorsteinsdottir U, Stefansson K. 2008. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 40:217-224.
11. Hunter DJ, Kraft P. 2007. Drinking from the fire hose-statistical issues in genomewide association studies. N Engl J Med 357:436-439.
12. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS et al. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40:189-197.
13. Kulathinal S, Karvanen J, Saarela O, Kuulasmaa K, for the MORGAM Project. 2007. Case-cohort design in practice-experiences from the MORGAM Project. Epidemiol Perspect Innov 4:15.
14. Kulathinal S, Niemelä M, Kuulasmaa K, contributors from Participating Centres, for the MORGAM Project. 2005. Description of MORGAM Cohorts. http://www.ktl.fi/publications/morgam/cohorts/index.html
15. Lasky-Su J, Lyon HN, Emilsson V, Heid IM, Molony C, Raby BA, Lazarus R, Klanderman B, Soto-Quiros ME, Avila L et al. 2008. On the replication of genetic associations: timing can be everything! Am J Hum Genet 82:849-858.
16. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9:356-369.
17. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR et al. 2007. A common allele on chromosome 9 associated with coronary heart disease. Science 316:1488-1491.
18. MORGAM Project. 2001-. MORGAM Manual. http://www.ktl.fi/publications/ morgam/manual/contents.htm
19. Niemelä M, Kulathinal S, Kuulasmaa K, for the MORGAM Project. 2007. Description and quality assessment of MORGAM data. http://www.ktl.fi/ publications/morgam/qa/contents.htm
20. Pastinen T, Perola M, Ignatius J, Sabatti C, Tainola P, Levander M, Syvanen AC, Peltonen L. 2001. Dissecting a population genome for targeted screening of disease mutations. Hum Mol Genet 10:2961-2972.
21. Pearson TA, Manolio TA. 2008. How to interpret a genome-wide association study. J Am Med Assoc 299:1335-1344.
22. R Development Core Team. 2008. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
23. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, Konig IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H. 2007. Genomewide association analysis of coronary artery disease. N Engl J Med 357:443-453.
24. Schunkert H, Gotz A, Braund P, McGinnis R, Tregouet DA, Mangino M, Linsel-Nitschke P, Cambien F, Hengstenberg C, Stark K et al. 2008. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 117:1675-1684.
25. Shi G, Rao DC. 2008. Ignoring temporal trends in genetic effects substantially reduces power of quantitative trait linkage analysis. Genet Epidemiol 32:61-72.
26. Silander K, Komulainen K, Ellonen P, Jussila M, Alanne M, Levander M, Tainola P, Kuulasmaa K, Salomaa V, Perola M, Poltonen L, Saarela J. 2005. Evaluating whole genome amplification via multiply-primed rolling circle amplification for SNP genotyping of samples with low DNA yield. Twin Res Hum Genet 8:368-375.
27. Sing CF, Stengard JH, Kardia SL. 2004. Dynamic relationships between the genome and exposures to environments as causes of common human diseases. World Rev Nutr Diet 93:77-91.
28. Strömberg U, Björk J, Broberg K, Mertens F, Vineis P. 2008. Selection of influential genetic markers among a large number of candidates based on effect estimation rather than hypothesis testing: an approach for genome-wide association studies. Epidemiology 19:302-308.
29. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. 1994. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583-612.
30. Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-678.
31. Zhao LP, Lipsitz S. 1992. Designs and analysis of two-stage studies. Stat Med 11:769-782.